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Abstract
Vaccination has reduced the global incidence of measles to the lowest rates in
history. Local interruption of measles transmission, however, requires sustained
high levels of population immunity that can be challenging to achieve and main-
tain. The herd immunity threshold for measles is typically stipulated at 90-95%.
This figure, however, does not easily translate into required immunity levels
across all age groups that would be sufficient to interrupt transmission. Previ-
ous estimates of such levels were based on speculative contact patterns based
on historical data from high-income countries. The aim of this study is to de-
termine age-specific immunity levels that would ensure elimination of measles
using observed contact patterns from a broad range of settings. We combined
recent observations on age-specific mixing patterns with scenarios for the dis-
tribution of immunity to estimate transmission potential. We validated these
models by deriving predictions based on serological studies and comparing them
to observed case data. We found that 95% immunity needs to be achieved at the
time of school entry to guarantee elimination. The level of immunity found in
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the 5-to-9 year old age group in serological studies was the strongest predictor
of future case load. Higher levels of immunity in 5-to-9 year olds are required
than the previously derived target of 90% to interrupt transmission. While such
high levels can be difficult to achieve, school entry provides a clear opportunity
to ensure sufficient levels of immunity.
Introduction
Measles, a highly contagious immunising infection, could be a future tar-
get for eradication.1,2 Since the introduction of vaccination in the late 1960s,
mortality and morbidity from measles has reduced drastically.3 Nevertheless,
outbreaks continue to occur, and achieving regional elimination, or interruption5
of transmission, has been challenging.4
Typically, immunity targets are set for the level of vaccination coverage at
birth required in infancy to achieve “herd immunity”, or the level of population
immunity necessary to prevent outbreaks occurring.5 For measles, this level is
usually in the range of 90-95%.6 Strictly speaking, however, any target based10
on vaccination coverage only applies to current and future birth cohorts going
forward. To assess the ability of a country or region to achieve and maintain
elimination at any point in time, one needs to look at immunity levels across
age groups. These levels are affected by historical routine vaccination coverage,
but also by vaccination campaigns and historical outbreaks and corresponding15
levels of natural immunity.
For this reason, in the late 1990s, the World Health Organization (WHO)
European Region derived age-specific target immunity profiles, or the levels
of immunity necessary in different age groups to achieve elimination.7 These
profiles are widely applied within and occasionally outside Europe.20
Based on a basic reproduction number (or number of secondary cases pro-
duced by a typical infective in a totally susceptible population) of 11 and as-
sumed age-specific contact patterns based on pre-vaccination data from England
and Wales, it was recommended to ensure that at least 85% of 1–4 year olds,
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90% of 5–9 year olds and 95% of 10 year olds and older possess immunity25
against measles.8 These immunity targets are different from recommendations
on vaccination coverage levels. Gaps in immunity can exist despite high routine
coverage if coverage targets were not met in the past, or because of population
migration. Immunity targets include the effect of immunity, or lack thereof, in
older age groups and highlights the potential need for campaigns to close any30
gaps in immunity.
Much work over the past decade has gone into better quantifying the amount
of transmission-relevant contact occurring between different age groups. Diary-
based studies have been conducted across Europe9,10, as well as in Viet Nam11
and China12, and elsewhere. While other methods for measuring social con-35
tact patterns exist13,14,15, contact data from diary studies have become the de
facto standard in studying age-specific infectious disease dynamics. Mathemat-
ical models of transmission based on these observed patterns have consistently
outperformed those based on homogeneous mixing.16,17,18
Here, we aimed to evaluate current guidelines on target immunity levels for40
measles using contact patterns observed in diary studies. To this end, we com-
bined the observed age-specific social mixing patterns with the recommended
immunity levels to calculate reproduction numbers in these scenarios to evaluate
the potential for sustained transmission if target immunity levels were achieved.
We further compared these to alternative scenarios of greater or lower immunity45
than currently recommended in specific age groups. We then used the results
from this analysis to compare the expected epidemiology from serological stud-
ies conducted around in the late 1990s / early 2000s with the observed case
loads in the subsequent 10 years.
Results50
Age-specific immunity scenarios
We first investigated reproduction numbers under previously recommended
target immunity levels (85% in under-5 year olds, 90% in 5–9 year olds and 95%
3
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in all older age groups).7 At these levels, the estimated reproduction numbers
derived taking into account age-specific mixing differed substantially from ones55
obtained under the assumption of homogeneous mixing (Fig. 1). With homoge-
neous mixing, all countries except Uganda were found to interrupt transmission
at the recommended immunity levels, with median reproduction numbers R less
than 1. For Uganda, the median estimate of the reproduction number at these
immunity levels would be 1.2, and the probability of having a reproduction60
number greater than 1 in this case would be 85%.
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Figure 1: Estimates of what the reproduction numbers of measles would be in a scenario of
immunity at current target levels, under assumptions of homogeneous (top) versus age-specific
(bottom) mixing. Selected countries are shown for clarity; a larger version of this graph with
more countries can be found in the Supplementary Material (Fig. S1).
When considering measured age-specific mixing patterns instead of assum-
ing homogeneous mixing, the ranges of reproduction numbers broadened, and
the reproduction numbers increased in almost all scenarios. The Netherlands,
Uganda, the United Kingdom and Taiwan all would have estimated reproduction65
number greater than 1 at previously recommended target levels when mixing
patterns were taken into account, indicating that continued outbreaks would be
possible. Germany, Italy, Finland and Viet Nam all would have more than 10%
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probability of R > 1 at these levels.
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Figure 2: Estimates of what the reproduction numbers of measles would be in different sce-
narios, with age-specific mixing as measured in diary studies. Top: Scenarios of immunity
levels. Bottom: Estimated reproduction numbers. Left to right: A) Current target levels. B)
5% higher immunity in under 5 year olds. C) 5% higher immunity in 5–9 year olds. D) 5%
lower immunity in 10–14 year olds. E) 5% higher immunity in 5–9 year olds and 5% lower
immunity in 15–19 year olds. F) 5% lower immunity in 15–19 year olds. Selected countries
are shown for clarity; a larger version of this graph with more countries can be found in the
Supplementary Material (Fig. S2).
With alternative scenarios, the reproduction numbers changed (Fig. 2). Rais-70
ing immunity in under-5-year olds by 5% to 90% would reduce the estimated
reproduction numbers slightly. In this scenario, all countries that would have
reproduction numbers greater than 1 under the previously recommended target
immunity levels would still have had reproduction numbers equal to or greater
than 1. Only in Germany and Italy would the estimated probabilities of having75
R > 1 drop to below 5%. On the other hand, raising immunity in 5-to-9-year
olds by 5% to 95% would sharply reduce reproduction numbers. In this scenario,
all countries would have a median estimated reproduction number well below
1, and only the Netherlands (10%) and Uganda (13%) would be estimated to
have a probability greater than 5% of having R > 1.80
Scenarios in which a gap in immunity is introduced in older generations
resulted in significantly higher reproduction numbers. Reducing immunity levels
5
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in 10-to-14-year olds by 5% to 90% compared to the previously recommended
target immunity levels would increase the median reproduction numbers in all
scenarios except Germany to above 1. Even if immunity in 5-to-9-year olds was85
increased to 95% at the same time, all countries would retain a high probability
of having R > 1 (Germany 30%, all other above 50%). Reducing immunity
in 14-to-19 year olds by 5% to 90% from the previously recommended target
immunity levels would increase the probabilities of R > 1 to greater than 50% in
all countries. Reducing immunity in all over-19 year olds by 5% to 90% from the90
previously recommended target immunity levels would increase the probabilities
of R > 1 to greater than 90% in all countries.
Evaluating age-specific immunity levels from serological studies
Reproduction numbers estimated based on immunity profiles measured in
the late 1990s / early 2000s were weakly correlated with the number of cases in95
the 10 subsequent years as per WHO figures (Spearman rank coefficient between
estimated R and cases per capita; homogeneous mixing model: 0.35, observed
mixing model: 0.49; Fig. 3A). Out of 17 countries in which serological studies
were conducted as part of the ESEN2 study, eight reported more than 5 measles
cases per million per year in the following 10 years. Of these, Spain (3419 cases100
over the course of 10 years) had a median estimated reproduction numbers of
0.19 (homogeneous mixing) and 0.54 (observed mixing), respectively, and prob-
ability 0 of a reproduction number greater than 1 with both models. Israel (1792
cases) had a median estimated reproduction number of > 0.9 in both models,
and a probability greater than 20% of R > 1 with both models. The United105
Kingdom (6601 cases) had a median reproduction number of 0.53 (homogeneous
mixing) and 1.1 (observed mixing), respectively, with corresponding probabil-
ities of 0% (homogeneous mixing) and 62% (observed mixing) of R > 1. The
other five countries (Belgium: 1066 cases, Bulgaria: 24,416 cases, Cyprus: 111
cases, Ireland: 1687 cases, Romania: 20,570 cases) all had median estimated110
reproduction numbers greater than 1 with both models and, correspondingly,
high probabilities of R > 1.
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Figure 3: Estimates derived from serological studies conducted around 2000 compared to
reported rate of cases across the following 10 years. Top (A): Estimated reproduction numbers
for measles under assumptions of homogeneous (left) and observed (right) mixing. Bottom (B):
Proportion estimated immune to measles from serological studies in the whole population (left)
and 5-to-9 year olds (right). Countries with estimated mean reproduction numbers greater
than 2 and/or more than 5 cases per million per year in the 10 years following the serological
study are highlighted in colour. Not shown in bottom right panel: Latvia (proportion of 5–9
year olds estimated immune: 62% (95% confidence interval, 57%–67%), 0.8 cases per million
per year).
Five further countries (Hungary, Latvia, Lithuania, Malta and Sweden) had
median estimated reproduction numbers greater than one with observed mixing,
but did not report many cases the following 10 years (maximum: 131 in Sweden).115
Of these, Cyprus and Latvia were estimated to have reproduction numbers well
above 1, while the others were closer to one, with probability of the reproduction
number being less than 1 greater than 15% in all cases except Lithuania (median
reproduction number: 1.4, 16 cases).
There is a negative correlation between population-level immunity levels as120
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determined from serology and outbreaks (Spearman rank coefficient between
estimated population-level immunity and cases per capita: -0.38; Fig. 3B, left),
with several outbreaks in countries reporting high levels of immunity (Israel,
Spain and the United Kingdom). The correlation is stronger when considering
only immunity in 5-to-9 year olds (Spearman rank coefficient between estimated125
immunity in 5-to-9 year olds and cases per capita: -0.62; Fig. 3B, right). Of the
6 countries (Czech Republic, Hungary, Luxembourg, Malta, Slovakia, Slovenia
and Sweden) that found a proportion greater than 94% of 5-to-9 year olds
immune in the serological studies, none experienced a significant outbreak in
the subsequent 10 years. Immunity in all other age groups were also negatively130
correlated with cases per capita over the next 10 years, but at lower levels of
correlation (0-to-4: -0.42; 10-to-14: -0.50; 15-19: -0.42, 20+: -0.06).
Discussion
Current guidelines on target immunity levels are based on estimates derived
almost 20 years ago, and were based on assumed mixing patterns matched135
to pre-vaccination data from England and Wales. We have used transmission
models in combination with recently observed age-specific contact patterns from
a variety of European and some non-European countries to assess whether these
guidelines are sufficient for achieving measles elimination.
We have investigated a range of countries with different demographic pro-140
files and cultural contexts: from high-income settings characterised by low birth
rates and an ageing population (e.g., Germany or the United Kingdom) to hav-
ing more (Viet Nam) or less (Taiwan) recently undergone the demographic tran-
sition to low birth rates, and Uganda as a low-income country characterised by
a high birth rate and young population. Investigating these scenarios with a145
model assuming homogeneous mixing, the estimated reproduction number with
given immunity levels depended solely on the demographic composition of the
population. In that case, only Uganda, which has a large proportion of children
in the population (35% of the population less then 10 years of age and therefore
8
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with immunity only at 90% in this scenario) would be expected to have a repro-150
duction number significantly greater than one under previously recommended
target immunity levels. With observed mixing patterns, more countries were
found to be at risk of outbreaks even if they achieved previously recommended
target immunity levels, including ones with very different demographic profiles.
This suggests that observed mixing patterns and, consequently, reproduction155
numbers are driven less by demography than by cultural and social contexts
such as schooling patterns, or differences in survey design and execution.
Of the countries investigated, Finland and the Netherlands have been ver-
ified to have eliminated measles.19 Finland eliminated indigenous measles in
the early 1990s, and has achieved vaccination coverage of greater than 95%160
since. The Netherlands have high immunity levels of more than 95% in 5-to-9
year olds, although immunity gaps at the sub-national level continue to cause
outbreaks.20,21
We estimated that achieving 95% immunity in 5-to-9 year olds would reduce
transmission sufficiently to achieve elimination in all except the most extreme165
scenarios. Verifying this finding with serological studies, we found that of the
countries estimated to have immunity levels greater than 94% in this age groups
none experienced a significant outbreak in the following 10 years. On the other
hand, only two of the 10 countries with mean immunity levels of less than 94%
in 5-to-9 year olds did not experience more than 5 cases per million per year in170
the following 10 years: Latvia and Lithuania. These two are among the smallest
in our group of countries for which we had serological data available and may
be at lower risk of imported cases. Still, they would have been expected to have
seen more cases given the results of the serological studies in 2003 and 2004,
respectively. Latvia in particular reported immunity levels as low as 76% among175
all age groups and 62% in 5-to-9 year olds in 2003, but only reported 16 cases of
measles in the 10 years 2004–13. To our knowledge, there were no supplementary
immunisation activities that could explain the absence of outbreaks. It would
be of value to determine whether these countries are now at high risk of large
outbreaks in spite of having previously interrupted transmission, or whether180
9
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there were issues with the serological tests conducted.
The importance of immunity levels in 5-to-9 year olds presents both a chal-
lenge and an opportunity: Levels as high as 95% in this age group can only be
maintained through high levels of two-dose immunisation prior to school entry.
At the same time, school entry itself involves a level of organisation which pro-185
vides the opportunity to both check the immunisation status of children and
offer additional vaccinations if necessary. The experience of the Pan-American
Health Organization in eliminating measles supports these findings. A key com-
ponent to interrupting measles transmission were periodic ’follow-up’ vaccina-
tion campaigns of pre-school children, timed at 4 year intervals to ensure high190
immunisation by the time of school entry.22,23 Studies in the United States,
where measles was eliminated in 2000, suggest that different minimum vaccine
coverage levels are required to prevent measles transmission among different age
groups.24 School-aged populations accounted for the majority of measles cases
between 1976 and 1988, and compulsory vaccination as part of school atten-195
dance laws played an important role in reducing measles incidence on the path
to elimination.25 Where there were less stringent vaccination requirements at
school entry, more case of measles were observed.26 Analyses of pre-elimination
measles outbreaks in the US indicated that transmission occurred among highly
vaccinated school-aged populations, indicating that higher population immunity200
levels are needed among school-aged children compared to preschool-aged chil-
dren.27 It has been suggested that minimum coverage levels as low as 80% at
the second birthday of children may be sufficient to prevent transmission among
preschool-aged children in the United States if population immunity is at least
93% among over-5 year olds.28205
While our results stress the role of 5-to-9 year olds, they also highlight the
importance of having no gaps in immunity in older age groups. This is partic-
ularly important close to elimination as a lower force of infection pushes cases
into older age groups.29 Given the higher rate of complications of measles when
experienced at older age, ensuring immunity among adults will be important210
not only for interrupting transmission, but also to prevent serious episodes of
10
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disease.30
Our study has several limitations. We relied on broad estimates of the basic
reproduction number, derived from pre-vaccination era dynamics.31 While these
numbers are well-established values in mathematical epidemiology, recent stud-215
ies have produced both lower and higher estimates, depending on the method
used and the type of setting investigated.32,33,34
Moreover, the reproduction numbers we estimated from serological studies
did not always correctly predict where outbreaks could be expected. In par-
ticular, Israel, Spain and the United Kingdom experienced large numbers of220
cases in the following 10 years in spite of reproduction number estimates which
would indicate interruption of transmission. Three potential causes for this dis-
crepancy suggest themselves: First, drops in vaccination coverage as well as
vaccination campaigns may have changed the risk of outbreaks during the 10
years following the serological studies. Second, samples used for the serological225
studies were a combination of residual and population-based samples and may
not be representative of population-level antibody levels. In Spain, a dispro-
portionate number of cases occurred in young adults35, but there was nothing
in the serological data to suggest that this might be expected. Moreover, if
those lacking immunity are preferentially in contact with each other because230
they cluster socially or geographically, outbreaks could occur in these groups,
and population-level serology might not provide a good estimate of realised
immunity levels in outbreak settings. In Israel, outbreaks occurred in ortho-
dox religious communities with very low vaccination coverage.36 Third, mixing
levels between 5-to-9 year olds might be even stronger than suggested by the235
diary-based studies underlying the contact matrices used here. This would be
in line with findings from the pre-vaccination era in England and Wales showing
a sharp increase in age-specific incidence at the age, coincident with the age of
first exposure to a school setting.37 Israel, Spain and the United Kingdom were
all found to have levels of immunity in 5-to-9 year olds of 90–95% in serological240
studies, and yet experienced significant outbreaks in the following 10 years. It
is conceivable that even these levels might be too low to guarantee interruption
11
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of transmission of measles, especially in the presence of sub-national variation
in immunity.
Lastly, we repeat that population immunity represents past levels of vaccine245
coverage or natural infection which may not be reflective of the future. For
example, immunity may be high just after a major outbreak but such outbreaks
could occur again if coverage is sub-optimal. An important caveat is therefore
that seeing immunity sufficient to interrupt transmission does not guarantee
that elimination is maintained if current of coverage are insufficient.250
In summary, we have tested different immunity thresholds for measles us-
ing observed mixing patterns between age groups. We found that previously
stated guidelines might be insufficient for interrupting transmission, and that
very high levels of immunity among 5-to-9 year olds while maintaining similarly
high levels in older age groups are paramount to achieving elimination. Further255
sub-national serological and epidemiological studies, particularly in low-income
countries at high risk of measles outbreaks, could generate key insights on the re-
lationship between immunity levels, heterogeneity of susceptibility and outbreak
risk.38,39 At the same time, further studies of contact patterns across settings,
combined with models of such patterns where no data have been collected, will260
make it possible to expand our results to other countries and regions.40 Com-
bined with observations of contact patterns, these would serve to highlight key
gaps in immunity that need to be filled in order to achieve regional elimination
and, ultimately, global eradication of measles.
Methods265
Age-specific forces of infection
We are considering an age-structured SIR-type model withA age groups.41,42
The force of infection λi experienced by age group i can be written as the sum
of the forces of infection exerted on those in age group i by those in the same
and all other age groups:270
λi =
∑
j
λij =
1
Ni
∑
j
βijIj (1)
12
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/201574doi: bioRxiv preprint first posted online Oct. 13, 2017; 
where λij is the force of infection exerted by age group j on age group i, βij
is the infection rate, or the rate at which infected individuals in age group j
contact and infect (if susceptible) individuals out of a total number Ni in age
group i, and Ij is the number of infectious people in age group j. This assumes
that the rate of infection between two random individuals depends on their ages275
only, and that the probability of a given member of age group i to be susceptible
depends on population-level susceptibility only.
The infection rate βij can be further split,
βij = pInfφij = pInfδjpij (2)
where pInf is the probability that a contact between an susceptible and infectious
person leads to infection, here assumed age-independent, φij is the number of280
contacts an individual of age group j makes with those of age group i per unit
time, δj is the rate at which individuals in age group j make contact with
others, or the number of people they meet per unit time (assumed independent
of population age structure), pij is the probability that a contact made by an
individual in age group j is with someone in age group i,
∑
i pij = 1285
Calculating the reproduction number
To estimate the reproduction number under different immunity profiles, we
calculate an immunity-adjusted contact probability
vij = pij(1− rj) (3)
where rj is the proportion of individuals in age group j that are immune, and
vij can be interpreted as the probability that a contact someone in age group i290
makes is with a non-immune person in age group j.
The basic reproduction number R0 is defined as the spectral radius (or
largest eigenvalue) of the next-generation matrix (NGM) K.43
R0 = ρ(K) (4)
13
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In our age-structured SIR-type model, the elements of the next-generation
matrix K are295
kij = qδjpij (5)
where q is a scale factor that, in the simplest SIR model, is the probability of
infection upon contact pInf multiplied with the duration of infectiousness DInf .
Given a value of R0 and a contact matrix, we can use Eqs. 4 and 5 to calculate q,
then calculate the elements of the reproduction matrix M, taking into account
immunity levels:300
mij = qδjvij (6)
and the reproduction number R as the spectral radius of M,
R = ρ(M) (7)
Contact matrices
We established contact matrices from diary studies conducted in a range
of different settings using a bootstrap, randomly sampling P individuals with
replacement from the P participants of a contact survey. We then determined a305
weighted average dij of the number of contacts in different age groups j made by
participants of each age group i, giving weekday contacts 5/2 times the weight of
weekend contacts. We further obtained symmetric matrices, i.e. ones fulfilling
cijnj = cjini by rescaling
cij =
1
2
1
ni
(dijnj + djini) (8)
where ni was the proportion of the underlying population that is in age group310
i. This gave the elements of the contact matrix φij = cij/T , scaled by the time
period T over which contacts were measured (usually 24 hours).
Homogeneous mixing approximation
An assumption of homogeneous mixing is equivalent to assuming that δi =
δ (each individual has the same number of contacts, no matter which age group315
they are in) and pij = nj (the probability of a contacts of group i being with
14
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group j is equal to the proportion of individuals that are in group j). For the
contact matrix D, this means that dij = δnj . This, in turn, means that the
infection rate is βij = δpinfnj and the force of infection (Eq. 1) is independent
of age group:320
λi ≈ δpinf I
N
(9)
This is equal to the classic SIR model with infection rate β if we set β = δpinf ,
that is the infection rate is equal to the rate of contact times the probability of
infection upon contact between a susceptible and infectious individual.
In this case the NGM of Eq. (5) reduces to
kij = qniδ (10)
with q = pInfDInf and spectral radius325
R0 = βDInf (11)
If the proportion immune of those in age group j is rj , the reproduction
matrix is
mij = q(1− ri)niδ (12)
and
R = βDInf
∑
j
(1− ri)ni = rR0 (13)
where r is the proportion of the population that is immune.
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